Astera Labs Reports Second Quarter 2026 Financial Results
- Record quarterly revenue of
$392.4 million , up 27% QoQ and up 104% year-over-year - Q2 revenue strength reflects diversified growth across AI fabrics and signal conditioning
- Q3 revenue inflection to be driven by Scorpio™ X-Series 320-lane fabric switch production ramp
“Astera Labs delivered outstanding Q2 2026 results, with record revenue of
Second Quarter of Fiscal 2026 Financial Highlights
GAAP Financial Results:
- Revenue of
$392.4 million , up 27% sequentially and up 104% year-over-year - GAAP gross margin of 73.3%
- GAAP operating income of
$89.2 million - GAAP operating margin of 22.7%
- GAAP net income of
$153.1 million - GAAP diluted net income per share of
$0.83
Non-GAAP Financial Results (1):
- Non-GAAP gross margin of 73.7%
- Non-GAAP operating income of
$153.5 million - Non-GAAP operating margin of 39.1%
- Non-GAAP net income of
$145.8 million - Non-GAAP diluted net income per share of
$0.80
____________________
(1) See “Reconciliation of GAAP to Non-GAAP Financial Measures” table included below.
Q2 2026 and Recent Business Highlights
- Expanded Taurus signal conditioning portfolio to include 3.2T Smart Retimers and Smart Redrivers for 224G Ethernet and UALink connectivity, purpose-built for AI infrastructure. The new Taurus Smart Signal Conditioners are the industry’s first OCP standard footprint compatible design to enable Smart Swap, which will give architects the flexibility to choose between low-power Smart Redrivers and long-reach Smart Retimers without board re-design. The expanded portfolio leverages Astera Labs’ Unified COSMOS software capabilities and will integrate telemetry, diagnostics, and intelligent link management to deliver advanced observability across high-speed interconnects.
- Showcased comprehensive portfolio updates at
Computex 2026 inTaiwan highlighting current AI rack-scale connectivity strategy and the first public demonstration of the Scorpio X-Series 320 Lane Smart Fabric Switch. Additional demonstrations included ultra-low latency optical connectivity, NVIDIA MGX-based reference designs, 200G/lane technology with SerDes diagnostics, COSMOS-enabled rack-level validation, and production ready systems fromAstera Labs and ecosystem partners. - Demonstrated ecosystem partnership and compatibility at AMD Advancing AI 2026 with multiple exhibits highlighting Astera Labs’ solutions to resolve data movement bottlenecks across PCIe, CXL, and Ethernet. Joint architectures included AMD Instinct platforms operating with Scorpio P-Series 320L for fabric optimization, Leo CXL memory controller for smart memory tiering, and Taurus 1.6T Smart Ethernet Retimers for scale-out connectivity, all with full-stack interop validated from end to end.
- Announced significant expansion of Astera Labs’
Taiwan operations andCloud-Scale Interop Lab , deepening the company’s presence within one of the world’s most important semiconductor ecosystems. Astera Labs’ expandedTaiwan footprint positions the company to bring together broader engineering, cross-functional support, and closer business coordination with key AI platform providers including AMD, Arm, Intel, and NVIDIA.
Third Quarter of Fiscal 2026 Financial Outlook
Based on current business trends and conditions,
GAAP Financial Outlook:
- Revenue within a range of
$540 million to$560 million - GAAP gross margin of approximately 72%
- GAAP operating expenses within a range of approximately
$232 million to$236 million - GAAP tax rate of approximately 4%
- GAAP diluted net income per share of approximately
$0.87 to$0.92 on weighted-average diluted shares outstanding of approximately 185 million
Non-GAAP Financial Outlook(2):
- Non-GAAP gross margin of approximately 72%
- Non-GAAP operating expenses within a range of approximately
$156 million to$160 million - Non-GAAP tax rate of approximately 12%
- Non-GAAP diluted net income per share of approximately
$1.16 to$1.21 on weighted-average diluted shares outstanding of approximately 185 million
____________________
(2) See “Reconciliation of GAAP to Non-GAAP Outlook” table included below.
Earnings Webcast and Conference Call
Discussion of Non-GAAP Financial Measures
We use certain non-GAAP financial measures, including those concerning our financial outlook, to supplement the performance measures in our consolidated financial statements, which are presented in accordance with GAAP. A reconciliation of these non-GAAP measures to the closest GAAP measure can be found later in this release. The timing and impact of any adjustments to arrive at the corresponding GAAP financial measures concerning our financial outlook are inherently dependent on future events that are typically uncertain or that may be outside of our control. These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income, and non-GAAP diluted net income per share. We use these non-GAAP financial measures for financial and operational decision-making and as a means to assist us in evaluating period-to-period comparisons. By excluding certain items that may not be indicative of our recurring core operating results, we believe that, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income, and non-GAAP diluted net income per share provide meaningful supplemental information regarding our performance. Accordingly, we believe these non-GAAP financial measures are useful to investors and others because they allow for additional information with respect to financial measures used by management in its financial and operational decision-making and they may be used by our institutional investors and the analyst community to help them analyze the health of our business. However, there are a number of limitations related to the use of non-GAAP financial measures, and these non-GAAP measures should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with GAAP. Other companies, including companies in our industry, may calculate these non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures.
We adjust the following items from one or more of our non-GAAP financial measures:
Stock-based compensation expense
We exclude non-cash stock-based compensation expense from certain of our non-GAAP financial measures because we believe that excluding this item provides meaningful supplemental information regarding operational performance. In particular, companies calculate non-cash stock-based compensation expense using a variety of valuation methodologies and subjective assumptions. Moreover, stock-based compensation expense is a non-cash charge that can vary significantly from period to period for reasons that are unrelated to our core operating performance, and therefore excluding this item provides investors and other users of our financial information with information that allows meaningful comparisons of our business performance across periods.
Acquisition-related costs
We exclude acquisition-related costs incurred in connection with our acquisitions, which we generally would have not otherwise incurred in the periods presented as part of our continuing operations. Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees. We believe that providing the non-GAAP measures excluding these costs assists our investors because such costs are not reflective of our ongoing operating results.
Income tax effect
This represents the impact of the non-GAAP adjustments on an after-tax basis and one-off discrete tax adjustments that are unrelated to our core operating performance in connection with the presentation of non-GAAP net income and non-GAAP net income per diluted share. This approach is designed to enhance investors’ ability to understand the impact of our non-GAAP tax expense on our current operations, provide improved modeling accuracy, and substantially reduce fluctuations caused by GAAP to non-GAAP adjustments.
Other
We exclude other adjustments, including non-cash fair value adjustments related to equity investments without readily determinable fair values. These investments are measured at cost and adjusted for observable price changes or impairment on a nonrecurring basis only upon the occurrence of certain events. Accordingly, these adjustments are not indicative of our core operating performance.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on
About
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands) |
||||||
| As of | ||||||
2026 |
2025 |
|||||
| Assets | ||||||
| Current assets | ||||||
| Cash and cash equivalents | $ | 111,453 | $ | 167,611 | ||
| Marketable securities | 1,141,505 | 1,021,205 | ||||
| Accounts receivable, net | 192,469 | 83,202 | ||||
| Inventory | 113,781 | 58,979 | ||||
| Prepaid expenses and other current assets | 92,687 | 31,033 | ||||
| Total current assets | 1,651,895 | 1,362,030 | ||||
| Property and equipment, net | 119,284 | 92,038 | ||||
| 91,557 | 19,015 | |||||
| Other assets | 68,765 | 58,740 | ||||
| Total assets | $ | 1,931,501 | $ | 1,531,823 | ||
| Liabilities and Stockholders’ Equity | ||||||
| Current liabilities | ||||||
| Accounts payable | $ | 53,930 | $ | 42,362 | ||
| Accrued expenses and other current liabilities | 110,377 | 90,680 | ||||
| Total current liabilities | 164,307 | 133,042 | ||||
| Other liabilities | 41,490 | 35,147 | ||||
| Total liabilities | 205,797 | 168,189 | ||||
| Stockholders’ equity | ||||||
| Common stock | 17 | 17 | ||||
| Additional paid-in capital | 1,485,320 | 1,348,969 | ||||
| Accumulated other comprehensive (loss) income | (3,369 | ) | 4,310 | |||
| Retained earnings | 243,736 | 10,338 | ||||
| Total stockholders’ equity | 1,725,704 | 1,363,634 | ||||
| Total liabilities and stockholders’ equity | $ | 1,931,501 | $ | 1,531,823 | ||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except per share amounts) |
||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||
2026 |
2026 |
2025 |
2026 |
2025 |
||||||||||
| Revenue | $ | 392,400 | $ | 308,361 | $ | 191,925 | $ | 700,761 | $ | 351,367 | ||||
| Cost of revenue | 104,833 | 73,220 | 46,362 | 178,053 | 86,393 | |||||||||
| Gross profit | 287,567 | 235,141 | 145,563 | 522,708 | 264,974 | |||||||||
| Operating expenses | ||||||||||||||
| Research and development | 135,898 | 125,634 | 66,724 | 261,532 | 131,278 | |||||||||
| Sales and marketing | 26,372 | 21,899 | 18,609 | 48,271 | 40,311 | |||||||||
| General and administrative | 36,049 | 25,775 | 20,456 | 61,824 | 42,326 | |||||||||
| Total operating expenses | 198,319 | 173,308 | 105,789 | 371,627 | 213,915 | |||||||||
| Operating income | 89,248 | 61,833 | 39,774 | 151,081 | 51,059 | |||||||||
| Interest and other income | 13,577 | 11,581 | 10,885 | 25,158 | 21,317 | |||||||||
| Income before income taxes | 102,825 | 73,414 | 50,659 | 176,239 | 72,376 | |||||||||
| Income tax benefit | 50,263 | 6,896 | 560 | 57,159 | 10,662 | |||||||||
| Net income | $ | 153,088 | $ | 80,310 | $ | 51,219 | $ | 233,398 | $ | 83,038 | ||||
| Net income per share attributable to common stockholders: | ||||||||||||||
| Basic | $ | 0.89 | $ | 0.47 | $ | 0.31 | $ | 1.36 | $ | 0.51 | ||||
| Diluted | $ | 0.83 | $ | 0.44 | $ | 0.29 | $ | 1.28 | $ | 0.47 | ||||
| Weighted-average shares used in calculating net income per share attributable to common stockholders: | ||||||||||||||
| Basic | 172,378 | 170,726 | 165,428 | 171,557 | 164,316 | |||||||||
| Diluted | 183,340 | 181,157 | 178,100 | 182,254 | 178,281 | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands) |
|||||||
| Six Months Ended |
|||||||
| 2026 | 2025 | ||||||
| Cash flows from operating activities | |||||||
| Net income | $ | 233,398 | $ | 83,038 | |||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||||
| Stock-based compensation | 112,905 | 77,920 | |||||
| Depreciation and amortization | 7,639 | 2,517 | |||||
| Non-cash operating lease expense | 2,718 | 1,522 | |||||
| Warrants contra revenue | 12,313 | 2,136 | |||||
| Accretion of discounts on marketable securities | (2,180 | ) | (4,489 | ) | |||
| Other, net | (2,961 | ) | 734 | ||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable, net | (109,461 | ) | 14,491 | ||||
| Inventory | (53,127 | ) | (14,577 | ) | |||
| Prepaid expenses and other assets | (41,422 | ) | (18,474 | ) | |||
| Accounts payable | 2,811 | 4,607 | |||||
| Accrued expenses and other liabilities | (357 | ) | (3,555 | ) | |||
| Net cash provided by operating activities | 162,276 | 145,870 | |||||
| Cash flows from investing activities | |||||||
| Purchases of property and equipment | (28,054 | ) | (6,562 | ) | |||
| Purchases of marketable securities | (359,732 | ) | (404,682 | ) | |||
| Sales and maturities of marketable securities | 233,933 | 343,611 | |||||
| Payments for business combinations, net of cash acquired | (69,214 | ) | — | ||||
| Other investing activities | (2,500 | ) | — | ||||
| Net cash used in investing activities | (225,567 | ) | (67,633 | ) | |||
| Cash flows from financing activities | |||||||
| Proceeds from exercises of stock options | 836 | 778 | |||||
| Proceeds from employee stock purchase plan | 6,294 | 4,345 | |||||
| Net cash provided by financing activities | 7,130 | 5,123 | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (56,161 | ) | 83,360 | ||||
| Cash, cash equivalents, and restricted cash | |||||||
| Beginning of the period | 167,684 | 80,044 | |||||
| End of the period | $ | 111,523 | $ | 163,404 | |||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited) (In thousands, except percentages and per share amounts) |
|||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||
2026 |
2026 |
2025 |
2026 |
2025 |
|||||||||||||||
| GAAP gross profit | $ | 287,567 | $ | 235,141 | $ | 145,563 | $ | 522,708 | $ | 264,974 | |||||||||
| Stock-based compensation expense | 1,692 | 499 | 353 | 2,191 | 315 | ||||||||||||||
| Non-GAAP gross profit | $ | 289,259 | $ | 235,640 | $ | 145,916 | $ | 524,899 | $ | 265,289 | |||||||||
| GAAP gross margin | 73.3 | % | 76.3 | % | 75.8 | % | 74.6 | % | 75.4 | % | |||||||||
| Stock-based compensation expense | 0.4 | 0.2 | 0.2 | 0.3 | 0.1 | ||||||||||||||
| Non-GAAP gross margin(1) | 73.7 | % | 76.4 | % | 76.0 | % | 74.9 | % | 75.5 | % | |||||||||
| GAAP operating income | $ | 89,248 | $ | 61,833 | $ | 39,774 | $ | 151,081 | $ | 51,059 | |||||||||
| Stock-based compensation expense | 63,992 | 48,913 | 35,474 | 112,905 | 77,920 | ||||||||||||||
| Acquisition-related costs(2) | 232 | 983 | — | 1,213 | — | ||||||||||||||
| Non-GAAP operating income | $ | 153,472 | $ | 111,729 | $ | 75,248 | $ | 265,199 | $ | 128,979 | |||||||||
| GAAP operating margin | 22.7 | % | 20.1 | % | 20.7 | % | 21.6 | % | 14.5 | % | |||||||||
| Stock-based compensation expense | 16.3 | 15.9 | 18.5 | 16.1 | 22.2 | ||||||||||||||
| Acquisition-related costs(2) | 0.1 | 0.3 | — | 0.2 | — | ||||||||||||||
| Non-GAAP operating margin(1) | 39.1 | % | 36.2 | % | 39.2 | % | 37.8 | % | 36.7 | % | |||||||||
| GAAP net income | $ | 153,088 | $ | 80,310 | $ | 51,219 | $ | 233,398 | $ | 83,038 | |||||||||
| Stock-based compensation expense | 63,992 | 48,913 | 35,474 | 112,905 | 77,920 | ||||||||||||||
| Acquisition-related costs(2) | 232 | 983 | — | 1,213 | — | ||||||||||||||
| Other(3) | (1,500 | ) | — | — | (1,500 | ) | — | ||||||||||||
| Income tax effect(4) | (69,996 | ) | (20,137 | ) | (8,670 | ) | (90,133 | ) | (23,308 | ) | |||||||||
| Non-GAAP net income | $ | 145,816 | $ | 110,069 | $ | 78,023 | $ | 255,883 | $ | 137,650 | |||||||||
| Net income per share attributable to common stockholders: | |||||||||||||||||||
| GAAP - basic | $ | 0.89 | $ | 0.47 | $ | 0.31 | $ | 1.36 | $ | 0.51 | |||||||||
| GAAP - diluted | $ | 0.83 | $ | 0.44 | $ | 0.29 | $ | 1.28 | $ | 0.47 | |||||||||
| Non-GAAP - diluted | $ | 0.80 | $ | 0.61 | $ | 0.44 | $ | 1.40 | $ | 0.77 | |||||||||
| Weighted average shares used to compute net income per share attributable to common stockholders: | |||||||||||||||||||
| GAAP - basic | 172,378 | 170,726 | 165,428 | 171,557 | 164,316 | ||||||||||||||
| GAAP - diluted | 183,340 | 181,157 | 178,100 | 182,254 | 178,281 | ||||||||||||||
____________________
(1) Total may not sum due to rounding.
(2) Acquisition-related costs included certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees.
(3) Other included non-cash and nonrecurring fair value adjustments on equity investments without readily determinable fair values.
(4) Income tax effect is calculated based on the tax laws in the jurisdictions in which we operate and is calculated to exclude the impact of stock-based compensation expense and one-off discrete tax adjustments that are unrelated to our core operating performance. For the three months ended
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK (Unaudited) (In millions, except percentages and per share amounts) |
|||||||
| Outlook for Three Months Ending |
|||||||
| Low | High | ||||||
| GAAP gross margin | 72 | % | 72 | % | |||
| Stock-based compensation expense | — | — | |||||
| Non-GAAP gross margin | 72 | % | 72 | % | |||
| GAAP operating expense | $ | 232 | $ | 236 | |||
| Stock-based compensation expense | (76 | ) | (76 | ) | |||
| Non-GAAP operating expense | $ | 156 | $ | 160 | |||
| GAAP tax rate | 4 | % | 4 | % | |||
| Income tax effect | 8 | 8 | |||||
| Non-GAAP tax rate | 12 | % | 12 | % | |||
| GAAP net income per share - diluted | $ | 0.87 | $ | 0.92 | |||
| Stock-based compensation expense | 0.40 | 0.40 | |||||
| Income tax effect | (0.11 | ) | (0.11 | ) | |||
| Non-GAAP net income per share - diluted | $ | 1.16 | $ | 1.21 | |||
SUPPLEMENTAL FINANCIAL INFORMATION STOCK-BASED COMPENSATION EXPENSE (Unaudited) (In thousands) |
||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||
2026 |
2026 |
2025 |
2026 |
2025 |
||||||||||
| Cost of revenue | $ | 1,692 | $ | 499 | $ | 353 | $ | 2,191 | $ | 315 | ||||
| Research and development | 36,413 | 29,404 | 17,852 | 65,817 | 37,038 | |||||||||
| Sales and marketing | 11,419 | 9,892 | 9,194 | 21,311 | 21,513 | |||||||||
| General and administrative | 14,468 | 9,118 | 8,075 | 23,586 | 19,054 | |||||||||
| Total stock-based compensation expense | $ | 63,992 | $ | 48,913 | $ | 35,474 | $ | 112,905 | $ | 77,920 | ||||
IR CONTACT:
leslie.green@asteralabs.com
Source: ASTERA LABS, INC.